Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Health Services Research (3)
- Public Health Education and Promotion (3)
- Behavior and Behavior Mechanisms (2)
- Chemicals and Drugs (2)
- Community Health and Preventive Medicine (2)
-
- Pharmaceutical Preparations (2)
- Psychiatry and Psychology (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Behavioral Medicine (1)
- Health Information Technology (1)
- Health and Medical Administration (1)
- Medical Education (1)
- Medical Specialties (1)
- Medicine and Health (1)
- Psychiatric and Mental Health (1)
- Quality Improvement (1)
- Social and Behavioral Sciences (1)
- Sociology (1)
- Therapeutics (1)
Articles 1 - 5 of 5
Full-Text Articles in Medicine and Health Sciences
Preferences For Support Resources Among Loved Ones Of Adults Prescribed Opioid Medications, Mansi Patel, Desta M. Pulley, Daniel Manvich
Preferences For Support Resources Among Loved Ones Of Adults Prescribed Opioid Medications, Mansi Patel, Desta M. Pulley, Daniel Manvich
Rowan-Virtua Research Day
The opioid epidemic continues to be a leading cause of overdose and related deaths in America. While most interventions are focused on the individuals with opioid and substance use disorder (OUD/SUD); the impact caregivers and family can have on the treatment of patients with OUD is non-existent. The purpose of this study is to collect pilot data on peers, friends, and family members of patients with SUD/OUD to understand the barriers in psychosocial support and maintaining treatment retention; barriers to accessing medication assisted therapy (MAT) and naloxone; and caregiver fatigue and barriers for caregivers. The collected data will be used …
Assessing The Effectiveness Of Phone Call Proactive Naloxone Co-Prescribing Enrollment, Tyler Klecha, David Aloisio, Eshani Choksi, Manasa Gowda, Christina Kanagawa, Charles M. Defendorf
Assessing The Effectiveness Of Phone Call Proactive Naloxone Co-Prescribing Enrollment, Tyler Klecha, David Aloisio, Eshani Choksi, Manasa Gowda, Christina Kanagawa, Charles M. Defendorf
Rowan-Virtua Research Day
Opioid use is increasing at never-before-seen rates. As a result, it is imperative that medical facilities educate and provide resources for those who may be at risk of an opioid overdose. With our study, we aimed to see the demographics of our population here at Rowan Medicine and identify associations of those participating in our naloxone co-prescription program. Majority of enrollees in our program were aged 50 or older and identified as Caucasian. A large proportion also reported being unable to work. Given this information, improvements in our naloxone coprescription program may include spreading more awareness of the benefits of …
The Opioid Epidemic & Narcan® Education: Current State Of Narcan® Use, Alicia Podwojniak, Fatimah Seyed-Ali, Akhil Abraham, Archana Salek
The Opioid Epidemic & Narcan® Education: Current State Of Narcan® Use, Alicia Podwojniak, Fatimah Seyed-Ali, Akhil Abraham, Archana Salek
Rowan-Virtua Research Day
Objectives:
- Investigate the need for increased naloxone awareness and availability in communities across the state [New Jersey]
- Assess the current advantages and disadvantages of Narcan® use
- Identify the barriers preventing naloxone from becoming a socially accepted treatment
- Develop an education plan to effectively teach target communities about Narcan® training and related resources/centers in that area.
What Motivates Patients To Enroll In A Naloxone Co-Prescribing Program?, Christina Kanagawa, David Aloisio, Eshani Choksi, Manasa Gowda, Tyler Klecha, Charles M. Defendorf
What Motivates Patients To Enroll In A Naloxone Co-Prescribing Program?, Christina Kanagawa, David Aloisio, Eshani Choksi, Manasa Gowda, Tyler Klecha, Charles M. Defendorf
Rowan-Virtua Research Day
Patients were contacted via phone call to establish knowledge of and prescription status regarding naloxone. They were then invited to enroll in a research study consisting of two online surveys.
The patients who had been prescribed naloxone by the time the study had started ranked being persuaded by a medical professional as being the most important reason for accepting the naloxone prescription.
Insufficient data collected during the six-week time frame to draw statistically significant conclusions about what motivates patients to receive naloxone co-prescriptions.
Correlations seen in this study are interesting and warrant further investigation.
Implementing Best Practices For Co-Prescribing Naloxone In Your Agency: A Guide For Healthcare Professions, Michael Anyanwu, Emmanuel Asenso Jr., Ahmad Hussein, Jessica Baaklini, Michael Sunderhauf
Implementing Best Practices For Co-Prescribing Naloxone In Your Agency: A Guide For Healthcare Professions, Michael Anyanwu, Emmanuel Asenso Jr., Ahmad Hussein, Jessica Baaklini, Michael Sunderhauf
Rowan-Virtua Research Day
From April 2020 to April 2021, it has been recorded that there have been 75,673 opioid overdose-related deaths in the United States. This number is up almost 20,000 more from the last period that deaths were recorded, coming in at 56,064 from April 2019 to April 2020. The use of naloxone, has been proven to save the lives of overdose patients on opioids by reversing its effects. It has already shown significant reduction in opioid overdose related mortality. Pharmacists are now able to prescribe naloxone with opioid prescriptions without a script from a doctor. EMS units are active in communities …